Clinical Trials Logo

Filter by:
NCT ID: NCT04828278 Completed - Clinical trials for Nutritional Supplementation

Nutrition21 Study 1

N21-1
Start date: April 6, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the effects of nooLVL containing arginine and inositol supplementation on executive function and memory prior to and following playing video games.

NCT ID: NCT04828265 Completed - Healthy Male Clinical Trials

Study of Aldafermin (NGM282) in Healthy Adult Male Japanese and Non-Japanese Subjects

Start date: April 13, 2021
Phase: Phase 1
Study type: Interventional

This is an open-label study to assess safety, tolerability, and pharmacokinetics of Aldafermin (NGM282) in healthy adult male Japanese and non-Japanese subjects

NCT ID: NCT04828135 Completed - Covid19 Clinical Trials

Dual MRI for Cardiopulmonary COVID-19 Long Haulers

Start date: May 26, 2021
Phase: Phase 2
Study type: Interventional

The next phase of the COVID-19 pandemic is likely to see a surge in an associated chronic cardiopulmonary disease that will challenge health systems. Recovered patients are presenting with persistent dyspnea at the Duke Pulmonary Post-COVID clinic. Evidence is now mounting that recovered patients have significant residual pulmonary disease, while myocardial injury has also been increasingly reported. To optimally care for these patients, Duke Pulmonary study team must comprehensively assess and monitor the changes in cardiopulmonary function and relate the changes to physiologic and quality of life outcomes. The study team will deploy cutting-edge MRI to fully characterize cardiopulmonary function in enrolled 30 subjects (accrual 23 subjects) at time point 60-120 days post recovery and 6-9 months later. Cardiac MRI will assess the myocardial status and right ventricular function, while hyperpolarized 129Xe MRI will provide a 3D assessment of pulmonary ventilation, interstitial barrier integrity, and pulmonary vascular hemodynamics. The overall objective outlined in this study is to demonstrate the feasibility and value of comprehensive longitudinal imaging characterization of cardiopulmonary structure and function in patients recovered from Covid-19.

NCT ID: NCT04828109 Completed - Surgery Clinical Trials

Digital Intervention Postoperative Protocol

Start date: October 25, 2021
Phase: N/A
Study type: Interventional

Postoperative recovery after head and neck surgery is complex, and often requires utilization of narcotic medications. The aim of this study is to evaluate reduction in pain and use of opioid medications through Virtual Reality (VR) and Fitbit wearable activity devices.

NCT ID: NCT04828031 Completed - Ulcerative Colitis Clinical Trials

Vitamin D Regulation of Gut Specific B Cells and Antibodies Targeting Gut Bacteria in Inflammatory Bowel Disease

Start date: July 1, 2021
Phase: Phase 1
Study type: Interventional

Specific Aim 1: Characterize the effects of vitamin D treatment on expression of α4β7 on B cells in patients with inflammatory bowel disease (IBD). Specific Aim 2: Determine the effects of vitamin D treatment on fecal immunoglobulins, percentage of Ig-coated gut bacteria, gut microbiome composition (global and bound by immunoglobulins) in patients with IBD and the association of these parameters with change in α4β7+ B cells . Specific Aim 3: Compare BCR repertoire (BCR clonotypes, immunoglobulin heavy chain gene (IGHV), and isotype usage) between α4β7+ and α4β7- B cells in patients with IBD and identify α4β7+ BCR clonotypes associated with Ig-bound gut bacteria .

NCT ID: NCT04828005 Completed - Pharmacodynamic Clinical Trials

Pharmacodynamic Evaluation of Intranasal Nalmefene

Start date: March 30, 2021
Phase: Phase 1
Study type: Interventional

This study is to determine the pharmacodynamics (the effects of the drug and mechanisms of their action within the body) of Nalmefene when given intranasally (IN; into the nose) compared to intranasal naloxone when given to healthy volunteers under steady state opioid agonism.

NCT ID: NCT04827875 Completed - Keloid Clinical Trials

Safety and Efficacy of AIV001 on Scar Formation and Keloid Recurrence Following Keloidectomy

Start date: June 23, 2021
Phase: Phase 1
Study type: Interventional

To evaluate how safe and effective AIV001 treatment is on scar formation and/or keloid recurrence following keloidectomy.

NCT ID: NCT04827693 Completed - Periodontitis Clinical Trials

The Cortical Shield for Facial Bone Reconstruction

Start date: January 3, 2019
Phase:
Study type: Observational

To evaluate a novel technique of bone regeneration and simultaneous implant placement in severely damaged sockets.

NCT ID: NCT04827680 Completed - Clinical trials for Acne Scars - Mixed Atrophic and Hypertrophic

Clinical Evaluation of the Safety and Performance of FRF for the Treatment and Reduction of Acne Scarring

Start date: May 1, 2021
Phase: N/A
Study type: Interventional

Prospective, single centre, evaluator-blind study of the safety and performance of fractional radiofrequency (RF) for the treatment and reduction of acne scarring. The study will evaluate the progress of 20 subjects requesting treatment of acne scarring. The study will involve three treatments on both sides of the face with 3-5 week intervals between each treatment. Subjects will be followed at 6 and 12 weeks after their last treatment. Analysis will be performed on all subjects who receive at least one treatment.

NCT ID: NCT04827654 Completed - Diet, Healthy Clinical Trials

Increasing Adoption of Fruits and Vegetables Into Family Diet

Start date: March 31, 2021
Phase: N/A
Study type: Interventional

The investigators are interested in maximizing the consumption of fruits and vegetables (F&V) in elementary school children by increasing the access to F&V by providing them in the home environment via direct delivery (F&V bag & recipes) and a gift card to purchase preferred choices. This also decreases barriers to trying F&V and switching to a more F&V-focused diet, e.g., access, cost, knowledge of what to do with fruits and vegetables by their families in household diet, and a period of time to try and get used to more F&V in the diet without worrying about access and cost. We hypothesize that at the end of 4 weeks, children in families that were given access to a F&V produce box with associated recipes, a gift card to purchase preferred choices, and a cooking incentive kit, consumed significantly better diets as measured with a diet composite score compared with children in families who did not receive increased F&V access.